ANMDMR - Nomenclatorul medicamentelor pentru uz uman
Actualizat în 27.11.2024
  Anulare filtru   Descarcă Varianta Excel
Denumire comercială  DCI  Forma farmaceutică  Cod ATC  Cod CIM  Firma / țara deținătoare APP 
VOYDEYA 50 mg+100 mg DANICOPANUM COMPR. FILM. L04AJ09 W70256001 ALEXION EUROPE SAS - FRANTA X
VOYDEYA 50 mg+100 mg DANICOPANUM COMPR. FILM. L04AJ09 W70256002 ALEXION EUROPE SAS - FRANTA X
VPRIV 400 unitati VELAGLUCERASE ALFA PULB. PT. SOL. PERF. A16AB10 W68150001 TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BR - IRLANDA X
VUEWAY 0,5 mmol/ml GADOPICLENOLUM SOL INJ. V08CA12 W70604001 BRACCO IMAGING S.P.A. - ITALIA X
VUEWAY 0,5 mmol/ml GADOPICLENOLUM SOL INJ. V08CA12 W70604002 BRACCO IMAGING S.P.A. - ITALIA X
VUEWAY 0,5 mmol/ml GADOPICLENOLUM SOL INJ. V08CA12 W70604003 BRACCO IMAGING S.P.A. - ITALIA X
VUEWAY 0,5 mmol/ml GADOPICLENOLUM SOL INJ. V08CA12 W70604004 BRACCO IMAGING S.P.A. - ITALIA X
VUMERITY 231 mg DIROXIMELUM FUMARAT CAPS. GASTROREZ. L04AX09 W68381001 BIOGEN NETHERLANDS B.V. - OLANDA X
VUMERITY 231 mg DIROXIMELUM FUMARAT CAPS. GASTROREZ. L04AX09 W68381002 BIOGEN NETHERLANDS B.V. - OLANDA X
VYDURA 75 mg RIMEGEPANT LIOF. ORAL N02CD06 W69731001 PFIZER EUROPE MA EEIG - BELGIA X
VYDURA 75 mg RIMEGEPANT LIOF. ORAL N02CD06 W69731002 PFIZER EUROPE MA EEIG - BELGIA X
VYEPTI 100 mg EPTINEZUMABUM CONC. PT. SOL. PERF. N02CD05 W69462001 H. LUNDBECK A/S - DANEMARCA X
VYEPTI 100 mg EPTINEZUMABUM CONC. PT. SOL. PERF. N02CD05 W69462002 H. LUNDBECK A/S - DANEMARCA X
VYNDAQEL TAFAMIDIS CAPS. MOI N07XX08 W64784002 PFIZER EUROPE MA EEIG - BELGIA X
VYNDAQEL TAFAMIDIS CAPS. MOI N07XX08 W64784003 PFIZER EUROPE MA EEIG - BELGIA X
VYNDAQEL TAFAMIDIS CAPS. MOI N07XX08 W66576001 PFIZER EUROPE MA EEIG - BELGIA X
VYVGART EFGARTIGIMODUM ALFA CONC. PT. SOL. PERF. L04AA58 W69156001 ARGENX BV - BELGIA X
VYVGART 1000 mg EFGARTIGIMODUM ALFA SOL. INJ. L04AA58 W70214001 ARGENX BV - BELGIA X
VYXEOS LIPOSOMAL 44 mg/100 mg COMBINATII (DAUNORUBICINUM+CYTARABINUM) PULB. PT. CONC. PT. SOL. PERF. L01XY01 W68462001 JAZZ PHARMACEUTICALS IRELAND LTD. - IRLANDA X
VYXEOS LIPOSOMAL 44 mg/100 mg COMBINATII (DAUNORUBICINUM+CYTARABINUM) PULB. PT. CONC. PT. SOL. PERF. L01XY01 W68462002 JAZZ PHARMACEUTICALS IRELAND LTD. - IRLANDA X